Isomorphic raises $2.1B to push AI-designed drugs toward clinic
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
3 artigos verificados sobre AlphaFold, produtos e movimentos do setor.
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
O novo campus da Google DeepMind em Seul aproxima o K-Moonshot da Coreia do Sul de modelos como AlphaFold e WeatherNext.
Demis Hassabis e John Jumper ganharam o Nobel de Química pelo AlphaFold 2, resolvendo o problema de dobramento de proteínas de 50 anos. DeepMind enfrenta o desafio de buscar novo avanço na era dos LLMs.